Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.61 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.61 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.61 |
| ▸ | MAOA | P21397 | 1/20 | 0.61 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.61 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.61 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.61 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.61 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.61 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.60 |
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.54 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.54 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.54 |
| ▸ | CXCR1 | P25024 | 2/20 | 0.54 |
| ▸ | CXCR2 | P25025 | 2/20 | 0.54 |
| ▸ | ALB | P02768 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isobutylbenzene SCHEMBL113603 | 0.97 | TAAR1 (0.58) | TAAR1SLC6A2SIGMAR1MAOASLC6A4 | |
| Isobutylbenzene SCHEMBL7493657 | 0.97 | SIGMAR1 (0.64) | TAAR1SLC6A2SIGMAR1MAOASLC6A4 | |
| Isobutylbenzene SCHEMBL2571645 | 0.97 | SIGMAR1 (0.64) | TAAR1SLC6A2SIGMAR1MAOASLC6A4 | |
| Isobutylbenzene SCHEMBL57393 | 0.97 | SIGMAR1 (0.64) | TAAR1SLC6A2SIGMAR1MAOASLC6A4 | |
| Isobutylbenzene SCHEMBL31498540 | 0.94 | SIGMAR1 (0.61) | TAAR1SLC6A2SIGMAR1MAOASLC6A4 | |
| Isobutylbenzene SCHEMBL6891614 | 0.94 | SIGMAR1 (0.61) | TAAR1SLC6A2SIGMAR1MAOASLC6A4 | |
| Isobutylbenzene SCHEMBL11468970 | 0.94 | TAAR1 (0.61) | TAAR1SLC6A2SIGMAR1MAOASLC6A4 | |
| Isobutylbenzene SCHEMBL31284788 | 0.94 | SIGMAR1 (0.61) | TAAR1SLC6A2SIGMAR1MAOASLC6A4 | |
| Isobutylbenzene SCHEMBL1894392 | 0.94 | SIGMAR1 (0.61) | TAAR1SLC6A2SIGMAR1MAOASLC6A4 | |
| Isobutylbenzene SCHEMBL6771248 | 0.93 | TAAR1 (0.54) | TAAR1SLC6A2SIGMAR1MAOASLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 238 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023132551-A1 | SAND FOR DIAGNOSING STATE OF ANIMAL URINE, METHOD FOR MANUFACTURING SAME, AND URINE STATE DIAGNOSIS METHOD USING SAME | 주식회사 퓨쳐바이오웍스 | 2023-07-13 | — | — | WO | claimed |
| EP-3237365-B1 | CYCLOALKANE OXIDATION CATALYSTS AND METHOD TO PRODUCE ALCOHOLS AND KETONES | RHODIA OPERATIONS (FR) | 2018-11-28 | — | — | EP | claimed |
| CN-105339332-B | Cycloalkanes oxidation catalyst and the method for production alcohol and ketone | 罗地亚经营管理公司 | 2018-04-10 | — | — | CN | claimed |
| EP-2877439-B1 | CYCLOALKANE OXIDATION CATALYSTS AND METHOD TO PRODUCE ALCOHOLS AND KETONES | RHODIA OPERATIONS (FR) | 2018-02-14 | — | — | EP | claimed |
| US-20170349524-A1 | Cycloalkane oxidation catalysts and method to produce alcohols and ketones | BASF SE (DE) | 2017-12-07 | — | — | US | claimed |
| EP-3237365-A1 | CYCLOALKANE OXIDATION CATALYSTS AND METHOD TO PRODUCE ALCOHOLS AND KETONES | Rhodia Operations (FR) | 2017-11-01 | — | — | EP | claimed |
| US-9745239-B2 | Cycloalkane oxidation catalysts and method to produce alcohols and ketones | RHODIA OPERATIONS (FR) | 2017-08-29 | — | — | US | claimed |
| CN-107108414-A | Cycloalkane oxidation catalyst and process for producing alcohol and ketone | 罗地亚经营管理公司 | 2017-08-29 | — | — | CN | claimed |
| US-9708238-B2 | Cycloalkane oxidation catalysts and method to produce alcohols and ketones | RHODIA OPERATIONS (FR) | 2017-07-18 | — | — | US | claimed |
| EP-2986585-B1 | CYCLOALKANE OXIDATION CATALYSTS AND METHOD TO PRODUCE ALCOHOLS AND KETONES | RHODIA OPERATIONS (FR) | 2017-06-21 | — | — | EP | claimed |
| CN-1639064-A | Titanosilicate, process for its production, and its use in producing oxidized compound | SHOWA DENKO KK (JP) | 2005-07-13 | — | — | CN | claimed |
| EP-1490300-A1 | TITANOSILICATE, PROCESS FOR ITS PRODUCTION, AND ITS USE IN PRODUCING OXIDIZED COMPOUND | Showa Denko K.K. (JP) | 2004-12-29 | — | — | EP | claimed |
| US-6759540-B2 | FOR USE AS OXIDATION CATALYST IN OXIDATION REACTION OF A COMPOUND HAVING A CARBON-CARBON DOUBLE BOND AND A OTHER FUNCTIONAL GROUP WHEREIN THE CARBON-CARBON DOUBLE BOND OF COMPOUND IS OXIDIZED BY USING A PEROXIDE AS AN OXIDIZING AGENT | SHOWA DENKO K.K. (JP) | 2004-07-06 | — | — | US | claimed |
| US-20040122243-A1 | Process for oxidizing carbon-carbon double bond and process for producing oxidized compounds | SHOWA DENKO K.K. (JP) | 2004-06-24 | — | — | US | claimed |
| CN-1466545-A | Crystalline MWW-type titanosilicates, their preparation and use in the production of epoxy compounds | �Ѻ͵繤��ʽ���� | 2004-01-07 | — | — | CN | claimed |
| US-6646102-B2 | Epoxidizing an alpha - halohydrin intermediate produced from a halide substitution of an alpha -dihydroxy derivative which has been obtained by a dihydroxylation reaction of an aryl allyl ether, oxidation catalysts | DOW GLOBAL TECHNOLOGIES INC. | 2003-11-11 | — | — | US | claimed |
| WO-2003074421-A1 | TITANOSILICATE, PROCESS FOR ITS PRODUCTION, AND ITS USE IN PRODUCING OXIDIZED COMPOUND | SHOWA DENKO K. K. (JP) | 2003-09-12 | — | — | WO | claimed |
| US-20030105268-A1 | Process for manufacturing an alpha-dihydroxy derivative and epoxy resins prepared therefrom | DOW GLOBAL TECHNOLOGIES INC. | 2003-06-05 | — | — | US | claimed |
| US-6500955-B1 | CONDENSING A HALO- QUINOLINE WITH AN ALPHA-PICOLYL DERIVATIVES IN THE PRESENCE OF A SOLVENT AND A PHASE TRANSFER CATALYST AT -10 TO 90 DEGREE C. TO FORM (2,8-BIS (TRIFLUOROMETHYL)-4-QUINOLINYL)-2-PYRIDINYLMETHANONE | NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (IN) | 2002-12-31 | — | — | US | claimed |
| US-20020188129-A1 | ONE POT SYNTHESIS OF [2, 8-BIS (TRIFLUOROMETHYL)-4- QUINOLINYL]2-PYRIDINYLMETHANONE, A MEFLOQUINE INTERMEDIATE | NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (IN) | 2002-12-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020188129-A1 | ONE POT SYNTHESIS OF [2, 8-BIS (TRIFLUOROMETHYL)-4- QUINOLINYL]2-PYRIDINYLMETHANONE, A MEFLOQUINE INTERMEDIATE | EIF2AK2, POLK, QARS1 | TAAR1 3976/4885SLC6A2 1668/4885SIGMAR1 1733/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.